These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 11366859)
1. What is happening to my body? Rappoport C WORLD; 1999 Nov; (No 103):4-6. PubMed ID: 11366859 [TBL] [Abstract][Full Text] [Related]
2. Fat, sugar and drugs on the French Riviera. Lands L GMHC Treat Issues; 1999 Mar; 13(3):9-11. PubMed ID: 11366205 [TBL] [Abstract][Full Text] [Related]
3. Are changes in body shape due to drug side effects? TreatmentUpdate; 1999 Jun; 11(4):3-4. PubMed ID: 11366790 [TBL] [Abstract][Full Text] [Related]
5. Wasting and body changes: what do we know so far? Gomez E Newsline People AIDS Coalit N Y; 1998 Sep; ():34-6. PubMed ID: 11367489 [TBL] [Abstract][Full Text] [Related]
6. Body composition changes with protease therapy. Berger D Posit Aware; 1998; 9(5):47. PubMed ID: 11365895 [TBL] [Abstract][Full Text] [Related]
7. Changes in body shape and metabolic abnormalities. Res Initiat Treat Action; 1999 Jan; 5(1):18. PubMed ID: 11366225 [TBL] [Abstract][Full Text] [Related]
8. Understanding and treating protease paunch. Vazquez E Posit Aware; 1999; 10(4):59-63. PubMed ID: 11366810 [TBL] [Abstract][Full Text] [Related]
9. On the trail of fugitive fat: the chase turns to NRTIs. Mascolini M J Int Assoc Physicians AIDS Care; 1999 Oct; 5(10):24-43. PubMed ID: 11366871 [TBL] [Abstract][Full Text] [Related]
11. Lipodystrophy in patients with HIV-1 infection: effect of stopping protease inhibitors on TNF-alpha and TNF-receptor levels, and on metabolic parameters. Maher B; Lloyd J; Wilkins EG; Fraser WD; Back D; Park BK; Pirmohamed M Antivir Ther; 2004 Dec; 9(6):879-87. PubMed ID: 15651746 [TBL] [Abstract][Full Text] [Related]
12. Effects of discontinuing stavudine or protease inhibitor therapy on human immunodeficiency virus-related fat redistribution evaluated by dual-energy x-ray absorptiometry. Tavassoli N; Bagheri H; Sommet A; Delpierre C; Marion-Latard F; Massip P; Aquilina C; Bonnet E; Obadia M; Labau E; Montastruc JL; Bernard J Pharmacotherapy; 2006 Feb; 26(2):154-61. PubMed ID: 16466321 [TBL] [Abstract][Full Text] [Related]
13. Absence of hypersensitivity to glucocorticoids in antiretroviral-associated lipodystrophy. Martin IP; Breen PA; Weigle DS Obes Res; 2003 Jan; 11(1):21-4. PubMed ID: 12529481 [TBL] [Abstract][Full Text] [Related]
14. Body composition changes in women. Proj Inf Perspect; 1999 Sep; (28):10. PubMed ID: 11367353 [TBL] [Abstract][Full Text] [Related]